The Effect of Telehealth Monitoring on Medication Compliance, Self-Efficacy and Quality of Life in Patients With İnflammatory Bowel Disease
This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.
• Individuals aged 18 years or older
• Able to read and write in Turkish
• Diagnosed with inflammatory bowel disease (IBD) for at least 6 months
• In clinical remission (Harvey-Bradshaw Index score \< 5 or Simple Clinical Colitis Activity Index score \< 3)
• Able to use a smartphone
• Have access to an online messaging application (e.g., WhatsApp) and a valid e-mail address
• Capable of downloading and using a mobile or computer-based video conferencing application (e.g., Zoom)
• Willing to participate in the study voluntarily